QUIX Quixote (MM)

	OMB APPROVAL
	OMB Number: 3235-145
	Expires: February 28, 2009
	Estimated average burden hours per response ... 15

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No.                      )*

QUIXOTE CORPORATION

 

(Name of Issuer)

Common Stock ($0.01-2/3 par value)

(Title of Class of Securities)

749056107

(CUSIP Number)

Belgrave Investment Holdings Limited
13 Chelsea Embankment
London, England SW3 4LA
44-207-352-6007

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

February 13, 2009

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § §240.1 3d- l(e), 240.13d-l(f) or 240.13d- l(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB control number.

 

 

SCHEDULE 13_D

SCHEDULE 13_D

SCHEDULE 13_D

Item 1. Security and Issuer .

The class of equity securities to which this Schedule 13D relates is the common stock, par value $0.01-2/3 per share (the “Common Shares”), of Quixote Corporation, a Delaware corporation (the “Company”). The principal executive offices of the Company are located at 35 East Wacker Drive, Chicago, Illinois 60601.

Item 2. Identity and Background.

(a)–(c) and (f) The names of the persons filing this statement on Schedule 13D are Belgrave Investment Holdings Limited (“Belgrave”), a United Kingdom company, and Leslie Welch Lawson (“Ms. Lawson”), a United States Citizen.

Belgrave is engaged in making investments in industrial companies. Leslie Welch Lawson owns 100% of the stock of Belgrave, and therefore is deemed to beneficially own the Company stock held by Belgrave. Ms. Lawson is also Belgrave’s Director and has voting and investment power with respect to all securities beneficially owned by Belgrave.

The principal office and business address of Belgrave and Ms. Lawson is 13 Chelsea Embankment, London, England SW3 4LA.

(d)–(e) Neither Belgrave nor Ms. Lawson has (a) been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors) or (b) been a party to any civil proceeding commenced before a judicial or administrative body of competent jurisdiction as a result of which it/she was or is now subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding any violations with respect to such laws.

Item 3. Source and Amount of Funds or Other Consideration .

All funds used to purchase the Common Shares on behalf of the Funds have come directly from the assets of Belgrave. See Item 5 for further information.

Item 4. Purpose of Transaction .

Belgrave purchased the Common Shares of the Company reported on this Schedule 13D for investment purposes. Belgrave intends to evaluate closely the performance of the Common Shares of the Company, including, without limitation, analyzing and assessing the Company’s business, assets, operations, financial condition, capital structure, management and prospects. Belgrave may, from time to time, evaluate various options in order to attempt to influence the performance of the Company and the activities of its Board of Directors. Depending on various factors, Belgrave may take such actions as it deems appropriate, including, without limitation, (i) engaging in discussions with management and/or the Board of Directors, (ii) communicating with other shareholders, (iii) making proposals to the Company concerning the operations of the Company, (iv) purchasing additional securities of the Company, (v) selling some or all of the securities of the Company, (vi) seeking to make a significant equity investment in the Company, (vii) assisting in providing financing for the company and/or formally requesting a seat on the Board of Directors, all in accordance with applicable securities laws.

SCHEDULE 13_D

Item 5. Interest in Securities of the Issuer.

Based upon information set forth in the Company’s most recent Quarterly Report on Form 10-Q, as filed with the Securities and Exchange Commission on February 9, 2009, there were 9,248,179 Common Shares of the Company issued and outstanding as of January31, 2009.

As of February 19, 2009, Belgrave held 1,215,942 Common Shares of the Company, or 13.1% of the Common Shares of the Company deemed issued and outstanding as of December 31, 2008.

The following table details all of the transactions in Common Shares of the Company, or securities convertible into, exercisable for or exchangeable for Common Shares of the Company, by the persons referenced in item 2 (each of which were effected by Belgrave in ordinary brokerage transactions), during the sixty (60) day period on or prior to February 23, 2009;

Date		Type of Transaction				Number of Shares				Security Type				Price per Share ($)
01/23/09		purchase					53,936			Common Shares				$	3.7036
01/26/09		purchase					156,375			Common Shares				$	3.8063
01/28/09		purchase					69,323			Common Shares				$	3.9897
01/29/09		purchase					2,700			Common Shares				$	4.0370
02/02/09		purchase					2,228			Common Shares				$	4.0449
02/03/09		purchase					32,593			Common Shares				$	4.0128
02/05/09		purchase					108			Common Shares				$	4.0463
02/06/09		purchase					21,300			Common Shares				$	4.0243
02/09/09		purchase					77,052			Common Shares				$	4.0100
02/10/09		purchase					12,554			Common Shares				$	4.0144
02/12/09		purchase					11,450			Common Shares				$	4.0144
02/13/09		purchase					117,976			Common Shares				$	4.0093
02/17/09		purchase					23,347			Common Shares				$	4.0142
02/18/09		purchase					8,000			Common Shares				$	4.0155
02/19/09		purchase					627,000			Common Shares				$	3.9042

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer .

Except as described herein, no contracts, arrangement, understandings or similar relationships exist with respect to the securities of the Company between the persons referenced in Item 2 of this Schedule 13D and any person or entity.

Item 7. Material to be Filed as Exhibits .

Not applicable.

SCHEDULE 13_D

SIGNATURE

After reasonable inquiry and to best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated March 4, 2009

		Belgrave Investment Holdings Limited
		By:		/s/ Leslie Welch Lawson
				Leslie Welch Lawson, Director Belgrave Investments Holdings Limited
		By:		/s/ Leslie Welch Lawson
				Leslie Welch Lawson

Quixote (NASDAQ:QUIX)
Gráfica de Acción Histórica
De Ene 2025 a Feb 2025

Quixote (NASDAQ:QUIX)
Gráfica de Acción Histórica
De Feb 2024 a Feb 2025